8. Summary
CLD is a significant cause of infant morbidity and mortality. The lung injury is multifactorial in origin with supplemental oxygen and ventilatory damage being only part of the picture. Antenatal and postnatal infection and inflammation are also important in the development of CLD, although their precise role has still to be fully ascertained.
In the future, therapeutic strategies need to be considered to decrease the incidence and severity of CLD. In particular a definitive trial investigating the role of antibiotics against Ureaplasma urealyticum in preventing CLD needs to be performed. Increased use of newer microbiological methods will also improve our understanding of the role of infection in CLD and further guide research and clinical management.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albertine, K.H., Jones, G.P., Starcher, B.C., Bohnsack, J.F., Davis, P.L., Cho, S.C., Carlton, D.P., Bland, R.D. (1999). Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med. 159: 945–58.
Bancalari, E., Claure, N., Sosenko, I.R. (2003). Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 8: 63–71.
Charafeddine, L., D’Angio, C.T., Phelps, D.L. (1999). Atypical chronic lung disease patterns in neonates. Pediatrics. 103: 759–65.
Clement, A., Chadelat, K., Sardet, A., Grimfeld, A., Tournier, G. (1988). Alveolar macrophage status in bronchopulmonary dysplasia. Pediatr Res. 23: 470–3.
Coalson, J.J. (2003). Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 8: 73–81.
Cordero, L., Ayers, L.W., Davis, K. (1997). Neonatal airway colonization with gram-negative bacilli: association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J. 16: 18–23.
Couroucli, X.I., Welty, S.E., Ramsay, P.L., Wearden, M.E., Fuentes-Garcia, F.J., Ni, J., Jacobs, T.N., Towbin, J.A., Bowles, N.E. (2000). Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res. 47: 225–32.
DiCosmo, B.F., Geba, G.P., Picarella, D., Elias, J.A., Rankin, J.A., Stripp, B.R., Whitsett, J.A., Flavell, R.A. (1994). Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest. 94: 2028–35.
Fanaroff, A.A., Wright, L.L., Stevenson, D.K., Shankaran, S., Donovan, E.F., Ehrenkranz, R.A., Younes, N., Korones, S.B., Stoll, B.J., Tyson, J.E., et al. (1995). Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am J Obstet Gynecol. 173: 1423–31.
Ghezzi, F., Gomez, R., Romero, R., Yoon, B.H., Edwin, S.S., David, C., Janisse, J., Mazor, M. (1998). Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol. 78: 5–10.
Goldenberg, R.L., Rouse, D.J. (1998). Prevention of premature birth. N Engl J Med. 339: 313–20.
Goldenberg, R.L., Hauth, J.C., Andrews, W.W. (2000). Intrauterine infection and preterm delivery. N Engl J Med. 342: 1500–7.
Groneck, P., Gotze-Speer, B., Oppermann, M., Eiffert, H., Speer, C.P. (1994). Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics. 93: 712–8.
Hannaford, K., Todd, D.A., Jeffery, H., John, E., Blyth, K., Gilbert, G.L. (1999). Role of ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 81: F162–7.
Hardie, W.D., Bruno, M.D., Huelsman, K.M., Iwamoto, H.S., Carrigan, P.E., Leikauf, G.D., Whitsett, J.A., Korfhagen, T.R. (1997). Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha. Am J Pathol. 151: 1075–83.
Hillier, S.L., Martius, J., Krohn, M., Kiviat, N., Holmes, K.K., Eschenbach, D.A. (1988). A case-control study of chorioamniotic infection and histological chorioamnionitis in prematurity. N Engl J Med. 319: 972–8.
Jobe, A.J. (1999). The new BPD: an arrest of lung development. Pediatr Res. 46: 641–3.
Jonsson, B., Rylander, M., Faxelius, G. (1998). Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr. 87: 1079–84.
Kenyon, S.L., Taylor, D.J., Tarnow-Mordi, W. (2001a). Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 357: 979–88.
Kenyon, S.L., Taylor, D.J., Tarnow-Mordi, W. (2001b). Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet. 357: 991–6.
Kenyon, S.L., Boulvain, M., Neilson, J. (2003). Antibiotics for preterm rupture of membranes. The Cochrane Database of Systematic Reviews. 2: CD001058.
King, J., Fenady, V. (2002). Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 4: CD000246.
Kotecha, S. (1996). Cytokines in chronic lung disease of prematurity. Eur J Pediatr. 155: S14–7.
Kotecha, S. (2000). Lung growth: implications for the newborn infant. Arch Dis Child Fetal Neonatal Ed. 82: F69–74.
Kotecha, S., Chan, B., Azam, N., Silverman, M., Shaw, R.J. (1995). Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 72: F90–6.
Kotecha, S., Wilson, L., Wangoo, A., Silverman, M., Shaw, R.J. (1996). Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res. 40: 250–6.
Kotecha, S., Silverman, M. (1999). Chronic Respiratory complications of neonatal disorders. Textbook of Pediatric Respiratory Medicine. Eds. Landau, L.I., Tausssig, L.M. Mosby. 488–521.
Kotecha, S., Hodge, R., Schaber, J.A., Miralles, R., Silverman, M., Grant, W.D. (2004). Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. Pediatr Res. 55: 61–8.
Kramer, B.W., Kramer, S., Ikegami, M., Jobe, A.H. (2002). Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol. 283: L452–9.
Liljedahl, M., Bodin, L., Schollin, J. (2004). Coagulase-negative staphylococcal sepsis as a predictor of bronchopulmonary dysplasia. Acta Paediatr. 93: 211–5.
Lyon, A.J., McColm, J., Middlemist, L., Fergusson, S., McIntosh, N., Ross, P.W. (1998). Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed. 78: F10–4.
Mabanta, C.G., Pryhuber, G.S., Weinberg, G.A., Phelps, D.L. (2003). Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev. 4: CD003744.
Miralles, R., Hodge, R., McParland, P.C., Field, D.J., Bell, S.C., Taylor, D.J., Grant, W.D., Kotecha, S. (2005). Relationship between antenatal inflammation and antenatal infection identified by detection of microbial genes by polymerase chain reaction. Pediatr Res. 57: 570–7.
Moss, T.J., Nitsos, I., Ikegami, M., Jobe, A.H., Newnham, J.P. (2005). Experimental intrauterine Ureaplasma infection in sheep. Am J Obstet Gynecol. 192: 1179–86.
Nelson, K.B., Dambrosia, J.M., Grether, J.K., Phillips, T.M. (1998). Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol. 44: 665–75.
Northway, W.H., Rosan, R.C., Porter, D.V. (1967). Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med. 276: 357–68.
Prösch, S., Lienicke, U., Priemer, C., Flunker, G., Seidel, W.F., Kruger, D.H., Wauer, R.R. Human adenovirus and human cytomegalovirus infections in preterm newborns: no association with bronchopulmonary dysplasia. Pediatr Res. 52: 219–24.
Rojas, M.A., Gonzalez, A., Bancalari, E., Claure, N., Poole, C., Silva-Neto, G. (1995). Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 126: 605–10.
Sawyer, M.H., Edwards, D.K., Spector, S.A. (1987). Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am J Dis Child. 141: 303–5.
Shankaran, S., Szego, E., Eizert, D., Siegel, P. (1984). Severe bronchopulmonary dysplasia. Predictors of survival and outcome. Chest 86: 607–10.
Speer, C.P. (1999). Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr. 158: S18–22.
Stancombe, B.B., Walsh, W.F., Derdak, S., Dixon, P., Hensley, D. (1993). Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin Infect Dis. 17: S154–7.
Tucker, J.M., Goldenberg, R.L., Davis, R.O., Copper, R.L., Winkler, C.L., Hauth, J.C. (1991). Etiologies of preterm birth in an indigent population: is prevention a logical expectation? Obstet Gynecol. 77: 343–7.
van Waarde, W.M., Brus, F., Okken, A., Kimpen, J.L. (1997). Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia. Eur Respir J. 10: 886–90.
Teberg, A.J., Pena, I., Finello, K., Aguilar, T., Hodgman, J.E. (1991). Prediction of neurodevelopmental outcome in infants with and without bronchopulmonary dysplasia. Am J Med Sci. 301: 369–74.
Wang, E.E., Ohlsson, A., Kellner, J.D. (1995). Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr. 127: 640–4.
Watterberg, K.L., Demers, L.M., Scott, S.M., Murphy, S. (1996). Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 97: 210–5.
Yoder, B.A., Coalson, J.J., Winter, V.T., Siler-Khodr, T., Duffy, L.B., Cassell, G.H. (2003). Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res. 54: 797–807.
Yoon, B.H., Romero, R., Jun, J.K., Park, K.H., Park, J.D., Ghezzi, F., Kim, B.I. (1997). Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 177: 825–30.
Yoon, B.H., Romero, R., Park, J.S., Chang, J.W., Kim, Y.A., Kim, J.C., Kim, K.S. (1998). Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol. 179: 1254–60.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Davies, P.L., Maxwell, N.C., Kotecha, S. (2006). The Role of Inflammation and Infection in the Development of Chronic Lung Disease of Prematurity. In: Pollard, A.J., Finn, A. (eds) Hot Topics in Infection and Immunity in Children III. Advances in Experimental Medicine and Biology, vol 582. Springer, Boston, MA . https://doi.org/10.1007/0-387-33026-7_9
Download citation
DOI: https://doi.org/10.1007/0-387-33026-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31783-0
Online ISBN: 978-0-387-33026-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)